MCTA Company Profile and Key Details

NASDAQ : MCTA

Charming Medical Class A Ordinary Shares

$29.36

1.855+6.75%

At Close 4:00 PM

Not Actively Trading

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Charming Medical Limited Class A Ordinary Shares (MCTA) stock surged +6.75%, trading at $29.36 on NASDAQ, up from the previous close of $29.36. The stock opened at $29.36, fluctuating between $29.36 and $29.36 in the recent session.

Stock Snapshot

29.355

Prev. Close

445.55M

Market Cap

29.355

Day Low

419.35714285714283

P/E Ratio

0.07

EPS (TTM)

N/A

Cash Flow per Share

29.36

Open

15.18M

Number of Shares

29.355

Day High

N/A

Free Float in %

N/A

Book Value

4.25M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 30, 2026	29.36	29.36	29.36	29.36	4.25M
Dec 09, 2025	29.35	29.35	29.35	29.35	4.25M
Nov 25, 2025	29.35	29.35	29.35	29.35	4.25M
Nov 11, 2025	28.35	31.70	25.90	29.35	4.24M
Nov 10, 2025	23.18	27.68	23.14	27.50	173.15K
Nov 07, 2025	20.74	22.55	20.62	22.10	94.04K
Nov 06, 2025	23.39	23.50	19.01	20.66	79.46K
Nov 05, 2025	22.12	23.96	21.71	22.60	82.27K
Nov 04, 2025	22.50	24.25	21.85	22.02	88.49K
Nov 03, 2025	24.64	24.88	22.22	22.49	99.86K
Oct 31, 2025	27.80	28.00	22.96	23.50	563.87K
Oct 30, 2025	19.12	31.24	18.50	27.76	727.34K
Oct 29, 2025	14.17	20.80	13.07	19.14	630.21K
Oct 28, 2025	9.60	14.42	9.20	14.21	1M
Oct 27, 2025	7.90	9.67	7.65	9.67	355.46K

Contact Details

Causeway Bay,

Hong Kong

852 211 61492

About Company

Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.

Stock Peers

ENSG

1.49+0.75%

The Ensign Group, Inc.$199.29 ADUS

-2.17-2.05%

Addus HomeCare Corporation$103.71 AMED

0.01+0.01%

Amedisys, Inc.$100.99 FSHCX

-0.9-0.91%

Health Care Services Portfolio$98.03 AMEH

-0.88-2.11%

Apollo Medical Holdings, Inc.$40.82 OPCH

-0.83-2.44%

Option Care Health, Inc.$33.17 PNTG

0.45+1.48%

The Pennant Group, Inc.$30.80 HCSG

-0.44-2.27%

Healthcare Services Group, Inc.$18.96 KDLYW

2.995+19.14%

Kindly MD, Inc.$18.65 ASTH

-2.51-11.90%

Astrana Health, Inc.$18.59

Company Overview

The stock is currently mid-range between its 52-week high and low $4.30 and $31.70. With a market capitalization of about $445.55 million, Charming Medical Limited Class A Ordinary Shares is classified as a small-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 874.28 thousand shares, trading with heavier-than-usual volume. Headquartered in Causeway Bay, None, Charming Medical Limited Class A Ordinary Shares operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Kit Wong, the company employs approximately 49 people and listed since October 21, 2025. Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 62.74%, SMA50 62.74%, SMA200 62.74%). The stock’s 14-day RSI is 78.51 (overbought), while the ATR of 4.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -7.4% below its high and over 582.67% above its low. Average 10-day trading volume of 4.25 million shares is slightly above the 3-month average of 3.43 million, indicating heightened recent market interest.

Valuation Metrics

Charming Medical Limited Class A Ordinary Shares trades at a P/E ratio of 414.66, slightly above the S&P 500 average, with a price-to-sales ratio of 71.61 and a price-to-book ratio of 10097.17 reflecting a rich premium to book value. The P/FCF stands at 3220.2, also above market averages. Compared to sector medians, Charming Medical Limited Class A Ordinary Shares P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Charming Medical Limited Class A Ordinary Shares last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $10.84. This means the shares are trading above this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, Charming Medical Class A Ordinary Shares has not generated any revenue.
On valuation metrics, Charming Medical Class A Ordinary Shares trades at a P/E of 414.66, P/S of 71.61 and P/B of 10097.17. Liquidity is tight, with a current ratio of 0.68 and quick ratio of 0.68. Operationally, the company’s inventory turnover is 76.18 and cash conversion cycle is 38.14 days. Debt-to-equity is 23.57, supported by a cash flow-to-debt ratio of 0.37.

Price Forecast & Outlook

Our AI price prediction model suggests that Charming Medical Limited Class A Ordinary Shares stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 18.04%, with price expected at $34.65 by February 13, 2026, within a range of $30.20 to $39.28 3-Month Outlook: Projected rise of 107.32%, reaching $60.86 by March 09, 2026, with a range of $60.86 to $60.86. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by December 09, 2026, within a range of $0.00 to $0.00.

Key Takeaways

currently trading near 52-week highs band. Valuation shows Charming Medical Limited Class A Ordinary Shares trading at a premium to the broader market with a P/E of 414.66. Our AI forecast model points to short-term strength (18.04% over two weeks), a medium-term rise (107.32% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Charming Medical Limited Class A Ordinary Shares (MCTA) stock price?

Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) stock price is $29.36 in the last trading session. During the trading session, MCTA stock reached the peak price of $29.36 while $29.36 was the lowest point it dropped to. The percentage change in MCTA stock occurred in the recent session was 6.75% while the dollar amount for the price change in MCTA stock was $1.86.

MCTA's industry and sector of operation?

The NASDAQ listed MCTA is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Charming Medical Limited Class A Ordinary Shares designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MCTA?

No Data

How MCTA did perform over past 52-week?

MCTA's closing price is 582.67% higher than its 52-week low of $4.30 where as its distance from 52-week high of $31.70 is -7.4%.

How many employees does MCTA have?

Number of MCTA employees currently stands at 49.

Link for MCTA official website?

Official Website of MCTA is:

How do I contact MCTA?

MCTA could be contacted at phone 852 211 61492 and can also be accessed through its website. MCTA operates from Hang Lung Centre, Causeway Bay, , Hong Kong.

How many shares of MCTA are traded daily?

MCTA stock volume for the day was 4.25M shares. The average number of MCTA shares traded daily for last 3 months was 874.28K.

What is the market cap of MCTA currently?

The market value of MCTA currently stands at $445.55M with its latest stock price at $29.36 and 15.18M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	49
Beta	0
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Care Facilities

MCTA Company Profile and Key Details

Charming Medical Class A Ordinary Shares

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Financial & Profitability Overview

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics